Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04450381 · ClinicalTrials.gov registry record · NA
Noninvasive Hemoglobin Testing, Prospective Blood Donors
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 131
- Enrollment target
NCT04450381 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 131 participants.
The verdict
NCT04450381, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 131 participants
- Enrollment target
Study Summary
The objective of this clinical investigation is to evaluate the pulse oximeter devices for screening prospective blood donors. The purpose study is to report on the accuracy of noninvasive hemoglobin (SpHb) as compared to hemoglobin measurements obtained from a laboratory hematology analyzer in a blood donation setting.
Interventions
- DEVICE Rad-67 Pulse oximeter & DCI Mini sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2020-06-23 |
| Est. Completion | 2020-07-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04450381
The ClinicalTrials.gov registry entry for NCT04450381 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rad-67 Pulse oximeter & DCI Mini sensor is the first listed.
NCT04450381 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04450381 about?
NCT04450381 is a clinical study titled "Noninvasive Hemoglobin Testing, Prospective Blood Donors". The objective of this clinical investigation is to evaluate the pulse oximeter devices for screening prospective blood donors. The purpose study is to report on the accuracy of noninvasive hemoglobin (SpHb) as compared to hemoglobin measurements obtained from a laboratory hematology analyzer in a bl...
What is the current status of trial NCT04450381?
This trial is currently completed. It is a NA study. The enrollment target is 131 participants. The study started on 2020-06-23. Estimated completion is 2020-07-07.
What interventions are being tested in trial NCT04450381?
The interventions under investigation include: Rad-67 Pulse oximeter & DCI Mini sensor (DEVICE).
Who is sponsoring clinical trial NCT04450381?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.